Nasus Pharma (NSRX) Assets (2024 - 2026)
Nasus Pharma (NSRX) reported Assets of $12.45 million for Q2 2026, compared with $639,000 a year earlier.
Analysis
Nasus Pharma (NSRX) Assets (2024 - 2026) Analysis & Trends
At the end of FY2025, Nasus Pharma posted Assets of $5 million, up 597.9% from FY2024.
- By year, Assets came in at $717,000 in FY2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Nasus Pharma | 27.23 Mn | 10.53 Mn | - | 12.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.45 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Jun 30, 2025 | 639,000.00 |
| Dec 31, 2024 | 717,000.00 |
API Access
Nasus Pharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=NSRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "NSRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=NSRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();